PT Haloni Jane Tbk

halo

Overview

HALO Overview

PT Haloni Jane Tbk is an Indonesia-based manufacturer that produces gloves. The Company is engaged in supplying disposable gloves to medical, dental, laboratories, beauty, food processing and industrial markets. It is a manufacturer and exporter of latex medical gloves for local and international brands. The Company’s products include Shamrock SUPREME Sterile Surgical Gloves Lightly Powdered, SHAMROCK SUPREME Latex Examination Gloves Powder Free, SHAMROCK SUPREME Sterile Latex Surgical Gloves Powder Free, and SHAMROCK PREMIUM Examination Gloves Powdered.

51015ValueCompetitiveFutureFinancialsDividend
Exchange
Indonesia Stock Exchange

Symbol: HALO

Development
Market Cap.
IDR 282.50Billion

~$17.65M USD

Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Supplies & Distributions
Sector
Healthcare

Valuation

HALO Valuation Metrics

50

IDR
0.0%

Closing Price on 2024-04-18

Price to Equity

6.47

P/E

At 6.47x P/E TTM, HALO.JK is trading at a discount to its peers in the Healthcare Equipment & Providers sector.

Price to Book

1.64

P/B

At 1.64x P/B TTM, HALO.JK is trading in line with its peers in the Healthcare Equipment & Providers sector.

Price to Sales

0.99

P/S

At 0.99x P/S TTM, HALO.JK is trading at a discount to its peers in the Healthcare Equipment & Providers sector.

Valuing PT Haloni Jane Tbk based on its trailing twelve months (TTM) valuation metrics against its peers in the Healthcare Equipment & Providers sector

Historical Price to Earnings

Other Valuation Metrics

Valuing PT Haloni Jane Tbk relative to other stocks in the Healthcare Equipment & Providers sector

Price/Cash Flow
-0.00x
Price/Forward Earnings
-
Enterprise Value/Revenue
1.04x
Enterprise Value/EBITDA
9.59x
PEG Ratio
0.05x

Analyst Ratings

No analyst ratings available yet.

Last closing: IDR502024-04-18
IDR 90.74

Considerably Higher Intrinsic Value: Analyst's intrinsic value is of HALO is IDR91, which is 82% higher than HALO's last closing price of IDR50 (as of 2024-04-18).

Valuation Recap of HALO stock
WeightNotesScore
High
The P/E ratio is calculated by dividing the market price of a company's stock by its earnings per share (EPS). It is a key tool for investors and analysts to assess whether a stock is overvalued, undervalued, or fairly valued. A P/E ratio of 6.47x is below the ID market average of 8.46x and is trading at a discount to peers in the Healthcare Equipment & Providers sector (16.91x).

High
The P/B ratio is calculated by dividing the market price of a company's stock by its book value per share (BVPS). It measures the company's stock value relative to its assets minus liabilities. A P/B ratio of 1.64x is similar to the peers average of 1.69x in the Healthcare Equipment & Providers sector.

Medium
The P/S ratio is calculated by dividing the market price of a company's stock by its sales per share. It measures the company's stock value relative to its sales. A P/S ratio of 0.99x is below the peers average of 2.87x in the Healthcare Equipment & Providers sector. When considered alongside the Forward Price/Earnings ratio, they serve to illustrate investors' expectations of HALO's valuation relative to its current sales and future earnings growth.

Low
The Price/Cash Flow ratio (P/CF) is calculated by dividing the market price of a company's stock by its cash flow per share. It measures the company's stock value relative to its cash flow, and is sometimes said to be a more objective measure of a company's value because cash flows cannot be manipulated as easily as earnings, which considers non-cash items such as depreciation and amortization. HALO's P/CF ratio of -0.00x is considered healthy by analysts.

Low
The Enterprise Value/Revenue ratio (EV/R) is calculated by dividing the enterprise value of a company by its revenue. It measures the company's enterprise value relative to its revenue. It is an indicator of how much it costs to buy the company's revenue; the lower the ratio, the cheaper the company's revenue. HALO's EV/R ratio of 1.04x is considered extremely underpriced by the market The average EV/R ratio for the Healthcare Equipment & Providers sector is 2.95x.

Medium
Considerably Higher Intrinsic Value: Analyst's intrinsic value is of HALO is IDR 90.74, which is 82% higher than HALO's last closing price of IDR 50.00.

Peers

HALO Peers and Comparison

Peer Companies

Supertype Fuzzy Search
SymbolCompany Name
Market Cap
(in Trillion IDR)
Total Assets
(in Trillion IDR)
Total Revenue
(in Trillion IDR)
Profit and Loss
(in Trillion IDR)
P/E
P/B
KLBFKalbe Farma Tbk65.45T27.06T 30.45T 2.77T 23.663.06
MIKAPT Mitra Keluarga Karyasehat Tbk.36.85T7.34T 4.26T 0.92T 40.236.33
SILOPT Siloam International Hospitals Tbk.31.10T10.98T 11.19T 1.21T 25.683.93
SRAJSejahteraraya Anugrahjaya Tbk20.58T5.61T 2.50T -0.04T -534.7211.09
SIDOPT Industri Jamu Dan Farmasi Sido Muncul Tbk19.95T3.89T 3.57T 0.95T 20.995.89
HEALPT Medikaloka Hermina Tbk.16.86T8.80T 5.78T 0.44T 38.544.36
PRAYPT Famon Awal Bros Sedaya Tbk9.56T4.70T 1.84T 0.22T 44.073.42
TSPCTempo Scan Pacific Tbk8.66T11.32T 13.12T 1.18T 7.351.12
SOHOPT Soho Global Health Tbk6.24T4.75T 8.20T 0.37T 16.822.60
OMEDPT Jayamas Medica Industri Tbk5.33T2.58T 1.74T 0.26T 20.552.40
Competitiveness Recap of HALO stock
WeightNotesScore
High
At a market cap of IDR 282.50 billion, HALO.JK ranks 10 in Market Cap out of 10 companies in the Healthcare sector.

High
At a PE of 6.47, HALO.JK ranks 9 out of 10 companies in the Healthcare sector for P/E value. The average PE is -31.09 (unadjusted). A high P/E ratio often indicates higher growth expectation, or other qualitative factors that led investors to believe that the company has a defensible competitive advantage compared to its peers in Healthcare. In this regard, it trails behind sector leaders such as PT Famon Awal Bros Sedaya Tbk (44.07) in the Healthcare sector.

Medium
At a PE of 6.47, HALO.JK is trading at a lower PE than that of its subsector peers in Healthcare Equipment & Providers (median of 16.91). A lower P/E value presents a potential value opportunity, but it might also indicate that the company is facing headwinds in its business.

Medium
At a revenue of IDR 0.28 trillion, HALO.JK ranks 10 in Revenue out of 10 companies in the Healthcare sector.

Medium
At a profit of IDR 0.04 trillion, HALO.JK ranks 9 in Profit out of 10 companies in the Healthcare sector.

Future

Future Growth of HALO

Growth Forecasts

No data available

Sector Benchmark

Healthcare Equipment & Providers companies in Indonesia are growing at a projected rate of 9.82% against the IDX average of +7.6%.

Healthcare Equipment & Providers sector overview
No data is available for HALO at the moment.
Future growth prospect of HALO
WeightNotesScore
High
HALO's projected growth rate of 9.82% is above the ID market average of 7.62%.

Medium
HALO and its peers in the Healthcare Equipment & Providers sub-sector belongs to the Healthcare sector. Companies in the Healthcare sector are projected to have a challenging year heading into 2024. Specifically, earnings are projected to decrease by 0.00% in 2024 while revenue growth is projected to decrease by -5.79%. These macroeconomic trends will likely be a headwind for HALO's earnings growth prospects in the next 2 years.

Loading...
Loading...

Management

Executive Management

President Director

Louis Hans Laurence15.2 years
Ester Susiana
Director
Jane Joe Laurence
Director
Juliana
Director
NamePositionShares%
Imelda LinPresident Commissioner4,618,0000.08
Juliana Director9,390,0000.17
Expressed in millions IDR, unless otherwise stated

Ownership

HALO Ownership

Others
19.83%
Insiders
80.17%
Institutions
0%
NameNumber of SharesOwnership (%)Value
Hansen4,536,745,70080.29226.84B
Public (Scripless)1,099,252,94119.4554.96B
Juliana 9,390,0000.170.47B
Imelda Lin4,618,0000.080.23B
Public (Scrip)500,0000.010.03B
No data is available for HALO at the moment.